Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: EXAS stock price vs SYK: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SYK's multiple
Needs SYK P/S.
Implied fair value · at EXAS's multiple
Needs EXAS P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EXAS FY 2025 (ended Dec 31, 2025) · SYK FY 2025 (ended Dec 31, 2025).
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
EXACT SCIENCES CORP · implied price per share
Bear
$0.03
Base
$0.03
Bull
$0.04
STRYKER CORP · implied price per share
Bear
$82.23
Base
$96.75
Bull
$111.26
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.02x
0.71x
Net debt / EBITDA
Leverage against operating earnings
-12.66x
1.87x
Cash and equivalents
Liquid reserves on the balance sheet
$964.71M
$4.10B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Guardant Health, Inc.
EXAS vs GH
Natera, Inc.
EXAS vs NTRA
NEOGENOMICS INC
EXAS vs NEO
OPKO HEALTH, INC.
EXAS vs OPK
LABCORP HOLDINGS INC.
EXAS vs LH
QUEST DIAGNOSTICS INC
EXAS vs DGX
ABBOTT LABORATORIES
EXAS vs ABT
JOHNSON & JOHNSON
EXAS vs JNJ
BAXTER INTERNATIONAL INC
EXAS vs BAX
INTUITIVE SURGICAL INC
EXAS vs ISRG
ALIGN TECHNOLOGY INC
EXAS vs ALGN
ARTIVION, INC.
EXAS vs AORT
$50.83M
$15.86B
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
